Tissue arrays (US Biomax, Inc.)were used to asses periostin expression in different stages of progression of ovarian and fallopian tube epithelial tumors and different histological types of ovarian cancer (Figure 8). This evidence concerns the gene POSTN and ovarian carcinoma.